Benzodiazepine effects on human sleep EEG spectra: a comparison of triazolam and flunitrazepam. 1998

X Tan, and S Uchida, and M Matsuura, and K Nishihara, and Y Iguchi, and T Kojima
Department of Neuropsychiatry, Nihon University School of Medicine.

The effects of 0.5 mg triazolam (TRI) and 4 mg flunitrazepam (FNZ) on the sleep electroencephalogram (EEG) were studied in eleven (six for TRI, and five for FNZ) healthy young male subjects. C3 EEG channel data of one baseline night, three drug nights and two withdrawal nights were recorded and their analyzed using a fast Fourier transformation (FFT) method. Changes in the 0.5 Hz to 40 Hz power spectrum showed that: 1) both TRI and FNZ increased higher frequency activity and reduced lower frequency activity on the drug nights; 2) on drug nights, NREM sigma frequency power was more strongly enhanced by TRI than FNZ, while the beta power of both NREM and REM was more strongly enhanced by FNZ than TRI; 3) NREM alpha power increased on the second night of withdrawal from both TRI and FNZ; 4) the power spectra for both NREM and REM sleep returned to baseline levels by the fourth night of withdrawal from either TRI or FNZ. These findings suggest that 0.5 mg TRI and 4 mg FNZ have both common and differing pharmacological effects on the central nervous system. Such differences could be caused by differences in the dose, half-life or systemic distribution of these two drugs.

UI MeSH Term Description Entries
D008297 Male Males
D004569 Electroencephalography Recording of electric currents developed in the brain by means of electrodes applied to the scalp, to the surface of the brain, or placed within the substance of the brain. EEG,Electroencephalogram,Electroencephalograms
D005445 Flunitrazepam A benzodiazepine with pharmacologic actions similar to those of DIAZEPAM that can cause ANTEROGRADE AMNESIA. Some reports indicate that it is used as a date rape drug and suggest that it may precipitate violent behavior. The United States Government has banned the importation of this drug. Fluridrazepam,Rohypnol,Fluni 1A Pharma,Flunibeta,Flunimerck,Fluninoc,Flunitrazepam-Neuraxpharm,Flunitrazepam-Ratiopharm,Flunitrazepam-Teva,Flunizep Von Ct,Narcozep,RO-5-4200,Rohipnol,Flunitrazepam Neuraxpharm,Flunitrazepam Ratiopharm,Flunitrazepam Teva,RO54200,Von Ct, Flunizep
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012890 Sleep A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility. Sleep Habits,Sleeping Habit,Sleeping Habits,Habit, Sleep,Habit, Sleeping,Habits, Sleep,Habits, Sleeping,Sleep Habit
D014229 Triazolam A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries. Apo-Triazo,Gen-Triazolam,Halcion,Trilam,U-33,030,Apo Triazo,Gen Triazolam,U 33,030,U33,030

Related Publications

X Tan, and S Uchida, and M Matsuura, and K Nishihara, and Y Iguchi, and T Kojima
January 1996, Life sciences,
X Tan, and S Uchida, and M Matsuura, and K Nishihara, and Y Iguchi, and T Kojima
January 1985, Current medical research and opinion,
X Tan, and S Uchida, and M Matsuura, and K Nishihara, and Y Iguchi, and T Kojima
January 1984, Current medical research and opinion,
X Tan, and S Uchida, and M Matsuura, and K Nishihara, and Y Iguchi, and T Kojima
March 1994, Psychopharmacology,
X Tan, and S Uchida, and M Matsuura, and K Nishihara, and Y Iguchi, and T Kojima
December 1998, Drug and alcohol dependence,
X Tan, and S Uchida, and M Matsuura, and K Nishihara, and Y Iguchi, and T Kojima
January 1985, Human neurobiology,
X Tan, and S Uchida, and M Matsuura, and K Nishihara, and Y Iguchi, and T Kojima
November 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
X Tan, and S Uchida, and M Matsuura, and K Nishihara, and Y Iguchi, and T Kojima
January 1983, British journal of clinical pharmacology,
X Tan, and S Uchida, and M Matsuura, and K Nishihara, and Y Iguchi, and T Kojima
May 1996, Psychopharmacology,
X Tan, and S Uchida, and M Matsuura, and K Nishihara, and Y Iguchi, and T Kojima
July 2002, Neuropharmacology,
Copied contents to your clipboard!